Genetic Engineering News and Research

RSS

Horizon Discovery announces divestment of animal models business to Envigo

Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation technologies, today announces an agreement to divest the Group’s animal research models business unit to Envigo RMS LLC.

From Revvity 11 Nov 2019

Researchers join forces to adapt novel genetic tool for zoonotic Chlamydia

The human pathogenic bacterium Chlamydia trachomatis is the most common sexually transmitted bacterial pathogen worldwide.

7 Nov 2019

Using high-resolution X-ray analysis to solve structure of stress proteins from Staphylococcus

Project leader, Head of Structural Biology Lab Konstantin Usachev explains, One of the main factors favoring a microorganism's survival in extreme conditions is preserving ribosomes - a macromolecular complex comprising RNA and proteins.

6 Nov 2019

Gene-editing technique CRISPR trialed for first time as cancer treatment

The go-ahead has been given for the first trials using CRISPR as an alternative therapy for treating cancer.

6 Nov 2019

Penn researchers tag CAR T cells with imaging markers to monitor cancer therapy

With CAR T cell therapy, a patient's own immune cells are genetically modified and inserted back into the body to find and kill cancer. This form of immunotherapy has already revolutionized some cancer treatments, but once the CAR T cells are inside a patient, where do they go? How do doctors know that they have successfully reached their target and that they are continuing to fight disease weeks, months, or even years later?

5 Nov 2019

Risk factors of malignant arrhythmias found in patients treated with therapeutic hyperthermia after cardiac arrest

Researchers showed that 20-50% of patients developed an irregular heartbeat that required defibrillation during the active cooling phase of therapeutic hypothermia following an out-of-hospital cardiac arrest.

5 Nov 2019

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

The University of Texas MD Anderson Cancer Center and Takeda Pharmaceutical Company Limited today announced an exclusive license agreement and research agreement to develop cord blood-derived chimeric antigen receptor-directed natural killer (CAR NK)-cell therapies, 'armored' with IL-15, for the treatment of B-cell malignancies and other cancers.

5 Nov 2019

Researchers produce synthetic phages that attack broader range of bacterial strains

Bacteriophages ("phages" for short) are viruses that infect bacteria. Phages are highly host-specific and will typically only infect and kill an individual species or even subspecies of bacteria. Compared to conventional antibiotics, phages do not indiscriminately kill bacteria.

4 Nov 2019

Researchers develop new type of transposase protein with improved biochemical properties

The team, comprising researchers from the European Molecular Biology Laboratory, the Universitätsklinikum Würzburg and the Paul-Ehrlich-Institut, managed to design a new variant of the Sleeping Beauty transposase with dramatically improved biochemical properties.

4 Nov 2019

UK aims to lead with cutting-edge radiation therapy

The UK is all set to launch its run into the future as the undisputed leader in the field of personalized and effective radiation therapy. The proposal is undergirded by a whopping £56 million, which will be used to set up and fund advanced radiation therapy research by a new collaborative setup, Cancer Research UK RadNet, over five years. This is the largest sum ever invested by this organization into radiotherapy research.

4 Nov 2019

Some deadly skin cancers may originate in hair follicles

Some deadly skin cancers may originate in the pigment-making stem cells in hair follicles rather than in skin.

4 Nov 2019

Some skin cancers may originate in hair follicles

Some of the most deadly skin cancers may start in stem cells that lend color to hair, and originate in hair follicles rather than in skin layers, a new study finds.

4 Nov 2019

Three UCLA researchers receive multimillion-dollar grant from state's stem cell agency

Three researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received awards totaling more than $18 million from the California Institute for Regenerative Medicine, the state's stem cell agency.

31 Oct 2019

Scientists modify a toxic protein to create a biosensor

Researchers have shown that the pore-forming toxin (PFT), aerolysin, could be used as a biosensor in the sequencing of DNA and proteins.

30 Oct 2019

New study compares two surgical approaches to endoscopic thyroid removal

A new study compares two surgical approaches to endoscopic thyroid removal, neither of which produces a scar in the neck area, providing a comprehensive comparison of the therapeutic effects and cosmetic results of each approach.

30 Oct 2019

Researchers make progress toward gene-based strategies to treat inherited neurometabolic diseases

Researchers are making great strides toward developing gene-based strategies to treat a variety of inherited neurometabolic diseases characterized by severe neurological involvement.

29 Oct 2019

NUS researchers use glowing nanoparticles to control biological processes

The biological technique of 'optogenetics' uses light to control cells within living tissues that have been genetically modified to be light-sensitive.

29 Oct 2019

Discovery of causal link between hydrogen sulfide and schizophrenia

Researchers from the RIKEN Center for Brain Science in Japan have found certain chemical markers that are associated with schizophrenia. They worked with lab mice with models of schizophrenia as well as post mortem brain specimens of persons with schizophrenia. The study titled, “Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology,” was published in the latest issue of the journal EMBO Molecular Medicine.

28 Oct 2019

Gene linked to schizophrenia likely confers risk for illness

Researchers have discovered in mice how one of the few genes definitively linked to schizophrenia, called SETD1A, likely confers risk for the illness. Mice genetically engineered to lack a functioning version of the enzyme-coding gene showed abnormalities in working memory, mimicking those commonly seen in schizophrenia patients.

24 Oct 2019

Researchers identify potential approach to stop growth of common brain tumor in children

University of North Carolina Lineberger Comprehensive Cancer Center researchers have identified a potential approach to stop the growth of the most common type of brain tumor in children.

24 Oct 2019

Genetic Engineering News and Research

Horizon Discovery announces divestment of animal models business to Envigo

Researchers join forces to adapt novel genetic tool for zoonotic Chlamydia

Using high-resolution X-ray analysis to solve structure of stress proteins from Staphylococcus

Gene-editing technique CRISPR trialed for first time as cancer treatment

Penn researchers tag CAR T cells with imaging markers to monitor cancer therapy

Risk factors of malignant arrhythmias found in patients treated with therapeutic hyperthermia after cardiac arrest

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

Researchers produce synthetic phages that attack broader range of bacterial strains

Researchers develop new type of transposase protein with improved biochemical properties

UK aims to lead with cutting-edge radiation therapy

Some deadly skin cancers may originate in hair follicles

Some skin cancers may originate in hair follicles

Three UCLA researchers receive multimillion-dollar grant from state's stem cell agency

Scientists modify a toxic protein to create a biosensor

New study compares two surgical approaches to endoscopic thyroid removal

Researchers make progress toward gene-based strategies to treat inherited neurometabolic diseases

NUS researchers use glowing nanoparticles to control biological processes

Discovery of causal link between hydrogen sulfide and schizophrenia

Gene linked to schizophrenia likely confers risk for illness

Researchers identify potential approach to stop growth of common brain tumor in children

Genetics & Genomics - Second Edition eBook

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News